Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer
暂无分享,去创建一个
K. Miller | M. Schrader | M. Schostak | H. Krause | C. Kempkensteffen | F. Christoph | S. Weikert | J. Kollermann
[1] A. Chokkalingam,et al. Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.
[2] Daniel Q. Naiman,et al. Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data , 2005, Bioinform..
[3] K. Desai,et al. Prostate cancer and the genomic revolution: Advances using microarray analyses. , 2005, Mutation research.
[4] Robert A Gardiner,et al. Use of multiple biomarkers for a molecular diagnosis of prostate cancer , 2005, International journal of cancer.
[5] P. Humphrey,et al. Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives , 2005, Scandinavian journal of urology and nephrology. Supplementum.
[6] Y. Shin,et al. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. , 2005, Gynecologic oncology.
[7] R. Sutherland,et al. Molecular markers of prostate cancer outcome. , 2005, European journal of cancer.
[8] Inge Jonassen,et al. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation. , 2005, International journal of oncology.
[9] Christian Pilarsky,et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival , 2005, The Journal of pathology.
[10] A. Partin,et al. Surgical margin status after radical retropubic prostatectomy , 2005, BJU international.
[11] O. Cussenot,et al. Cancer de la prostate. Épidémiologie. Facteurs de risques. Anatomopathologie , 2004 .
[12] W. Isaacs,et al. Improved biomarkers for prostate cancer: a definite need. , 2004, Journal of the National Cancer Institute.
[13] S. Loening,et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer , 2004, The Prostate.
[14] O. Cussenot,et al. [Prostate cancer. Epidemiology. Risk factors. Pathology]. , 2004, Annales d'urologie.
[15] D. Figarella-Branger,et al. CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle , 2004, Acta Neuropathologica.
[16] C. Pilarsky,et al. CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] Henrik Grönberg,et al. Prostate cancer epidemiology , 2003, The Lancet.
[18] I. Petersen,et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients , 2003, British Journal of Cancer.
[19] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[20] C. Pilarsky,et al. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. , 2002, The American journal of pathology.
[21] T. Barrette,et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.
[22] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[23] W. Liu,et al. Identification and characterization of amino acid starvation-induced CD24 gene in MCF-7 human breast cancer cells. , 2000, International journal of oncology.
[24] P. Altevogt,et al. CD24 is a marker for human breast carcinoma. , 1999, Cancer letters.
[25] L. Distel,et al. CD24 promotes invasion of glioma cells in vivo. , 1999, Journal of neuropathology and experimental neurology.
[26] P. Altevogt,et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. , 1997, Blood.
[27] H. Hsu,et al. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. , 1995, Cancer research.
[28] Philip Smith,et al. Expression of a B‐cell marker, CD24, on nasopharyngeal carcinoma cells , 1995, International journal of cancer.
[29] J. Kemp,et al. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia. , 1994, American journal of clinical pathology.
[30] R. Stahel,et al. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. , 1992, Cancer research.
[31] J. Gogusev,et al. Expression of the human nephron differentiation molecules in renal cell carcinomas. , 1990, The American journal of pathology.
[32] T. Lebien,et al. The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. , 1986, Journal of immunology.
[33] W. A. Soanes,et al. Precipitating antigens of the normal human prostate. , 1970, Journal of reproduction and fertility.